Intelligent Bio Solutions (INBS) Cash from Investing Activities (2022 - 2025)
Intelligent Bio Solutions' quarterly Cash from Investing Activities came in at -$14385.0 in Q1 2025, down 663.9% year-on-year from $2551.0 in Q1 2024, and down 663.9% quarter-over-quarter from $2551.0 in Q1 2024.
Intelligent Bio Solutions has reported Cash from Investing Activities for 4 years, with the latest figure at -$14385.0 in Q1 2025.
- For the quarter ending Q1 2025, Cash from Investing Activities fell 663.9% year-over-year to -$14385.0; the trailing twelve-month figure through Mar 2025 stood at -$19781.0 (up 90.87% YoY), and the FY2023 full-year result was -$694142.0, up 21.14% from the prior year.
- Cash from Investing Activities for Q1 2025 stood at -$14385.0, down from $2551.0 in the prior quarter.
- The five-year high for Cash from Investing Activities was $173803.0 in Q1 2023, with the low at -$703013.0 in Q2 2022.
- Average Cash from Investing Activities over 4 years is -$201284.1, with a median of -$181750.0 recorded in 2023.
- Year-over-year, Cash from Investing Activities jumped 74.15% in 2023 and plunged 663.9% in 2025.
- Tracing INBS's Cash from Investing Activities over 4 years: stood at -$211304.0 in 2022, then rose by 13.99% to -$181750.0 in 2023, then surged by 101.4% to $2551.0 in 2024, then sank by 663.9% to -$14385.0 in 2025.
- The last three Cash from Investing Activities figures came in at -$14385.0 (Q1 2025), $2551.0 (Q1 2024), and -$181750.0 (Q2 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -20.32 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -185.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -816.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -591.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -92.80 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -475.32 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | -298.50 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -2.50 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | -217.20 Mn |
| 10 | Intelligent Bio Solutions | 13.61 Mn | 12.40 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | -14,385.00 |
| Mar 31, 2025 | -14,385.00 |
| Mar 31, 2024 | 2,551.00 |
| Mar 31, 2024 | 2,551.00 |
| Jun 30, 2023 | -181,750.00 |
| Jun 30, 2023 | -181,750.00 |
| Mar 31, 2023 | 173,803.00 |
| Mar 31, 2023 | 173,803.00 |
| Dec 31, 2022 | -211,304.00 |
| Dec 31, 2022 | -211,304.00 |
| Sep 30, 2022 | -474,891.00 |
| Sep 30, 2022 | -474,891.00 |
| Jun 30, 2022 | -703,013.00 |
| Jun 30, 2022 | -703,013.00 |